Too Premature to Deny the Potential of Thrombomodulin-Alfa in Idiopathic Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine - United States
doi 10.1164/rccm.202002-0271le
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Thoracic Society

Related search

Reply To: Too Premature to Deny the Potential of Thrombomodulin-Alfa in Idiopathic Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2020English

Idiopathic Pulmonary Fibrosis

Pulmonologiya
PulmonaryRespiratory Medicine
2015English

Idiopathic Pulmonary Fibrosis

2020English

The Pathogenesis of Idiopathic Pulmonary Fibrosis

Therapeutic Advances in Respiratory Disease
PulmonaryRespiratory MedicinePharmacology
2010English

Epigenomics of Idiopathic Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2012English

Imaging: How to Recognise Idiopathic Pulmonary Fibrosis

European Respiratory Review
PulmonaryRespiratory Medicine
2014English

Advances in the Management of Idiopathic Pulmonary Fibrosis

F1000 Medicine Reports
2010English

Managing Comorbidities in Idiopathic Pulmonary Fibrosis

International Journal of General Medicine
Medicine
2015English

The Genetic Basis of Idiopathic Pulmonary Fibrosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy